Larry Lofgreen

Asia Pacific Sales and Solutions Consulting, VP

Larry Lofgreen joined Health Catalyst in July 2014 as a Data Architect.Prior to coming to HC, he co-founded Cogent Works, a property and casualty pharmacy benefits manager. Larry holds a JD, MBA and BS degree in computational mathematics from Brigham Young University.

See content from Larry Lofgreen

2021 Asia-Pacific Healthcare Trends: Growing Digitization, Universal Health Coverage, and More

Along with the rest of the globe, 2021 healthcare trends across Asia-Pacific (APAC) countries will center on COVID-19 recovery and resuming the healthcare improvement journey. In the APAC region, however, a mix of developed and developing countries poses unique challenges, as healthcare access and basic infrastructure vary widely between urban and rural populations and economic levels. To shepherd healthcare out of the pandemic and enhance delivery overall in 2021, APAC nations will focus on increasing investment in digital health (including virtual care, machine learning, and EMR adoption), achieving universal health coverage, shifting more towards value, and improving payer-provider relationships.

2021 Asia-Pacific Healthcare Trends: Growing Digitization, Universal Health Coverage, and More (White Paper)

Along with the rest of the globe, 2021 healthcare trends across Asia-Pacific (APAC) countries will center on COVID-19 recovery and resuming the healthcare improvement journey. In the APAC region, however, a mix of developed and developing countries poses unique challenges, as healthcare access and basic infrastructure vary widely between urban and rural populations and economic levels. To shepherd healthcare out of the pandemic and enhance delivery overall in 2021, APAC nations will focus on increasing investment in digital health (including virtual care, machine learning, and EMR adoption), achieving universal health coverage, shifting more towards value, and improving payer-provider relationships.

How a U.S. COVID-19 Data Registry Fuels Global Research

In addition to driving COVID-19 understanding within the United States, a national disease registry is informing research beyond U.S. borders. Clinicians with the Singapore Ministry of Healthcare Office for Healthcare Transformation (MOHT) have used Health Catalyst Touchstone® COVID-19 data to develop a machine learning tool that helps predict the likelihood of COVID-19 mortality. With this national data set that leverages deep aggregated EHR data, the MOHT accessed the research-grade data it needed to build a machine-learning algorithm that predicts risk of death from COVID-19. The registry-informed prediction model was accurate enough to stand up to comparisons in the published literature and promises to help inform vaccine research and, ultimately, allocation of vaccines within populations.

How a U.S. COVID-19 Data Registry Fuels Global Research

In addition to driving COVID-19 understanding within the United States, a national disease registry is informing research beyond U.S. borders. Clinicians with the Singapore Ministry of Healthcare Office for Healthcare Transformation (MOHT) have used Health Catalyst Touchstone® COVID-19 data to develop a machine learning tool that helps predict the likelihood of COVID-19 mortality.
With this national data set that leverages deep aggregated EHR data, the MOHT accessed the research-grade data it needed to build a machine-learning algorithm that predicts risk of death from COVID-19.
The registry-informed prediction model was accurate enough to stand up to comparisons in the published literature and promises to help inform vaccine research and, ultimately, allocation of vaccines within populations.

This site uses cookies

We take pride in providing you with relevant, useful content. May we use cookies to track what you read? We take your privacy very seriously. Please see our privacy policy for details and any questions.